Journal profile · Biochemical Research Methods
Expert Review of Proteomics
ISSN 1478-9450 · eISSN 1744-8387 · Taylor and Francis Ltd. · ENGLAND · Bimonthly · Founded 2004
Expert Review of Proteomics: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 2.93; JCR Q2 (journal website); hybrid open access; APC charged, amount not published; median 82 days to acceptance (75 articles, last 24 months); community-reported acceptance: moderate; 47 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Expert Review of Proteomics is published by Taylor and Francis Ltd. and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Proteomics Techniques and Applications, Mass Spectrometry Techniques and Applications and Metabolomics and Mass Spectrometry Studies, together about 50% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Expert Review of Proteomics [ISSN 1478-9450]; [e-ISSN 1744-8387] is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original research focusing on clinical aspects of proteomics. The journal publishes both Gold Open Access and Subscription content. Expert Review of Proteomics publishes reviews, commentary and original research from the fields of clinical and translational proteomics and related fields to advance scientific understanding of the many varied roles protein expression plays in human health and disease. Papers focus on studies of the following to understand their role in clinical health (including how these can advance therapeutics) and the value that this has for precision medicine and patients generally: - Biological pathways and proteins on a human cellular and tissue level - Functional and structural proteomics - Quantitative and qualitative profiling - Evaluations, recent advancements, discoveries, observation, applications, implications, interactions, diagnostics, prognostics, proteomic profiling techniques and technological developments in the following: Biological mass spectrometry Protein arrays Interaction maps Data archives Biological assays Performance of new technologies and prospects for future drug discovery We encourage articles that discuss the combination of proteomics with lipidomics, glycomics, metabolomics, epigenomics and multi-omics. Please note that the journal does not publish case reports or case series. Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results; Article Highlights – an executive summary of the author’s most critical points. Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees. Reach an international clinical and medical audience alongside other key opinion leaders in your field by publishing with Expert Review of Proteomics, part of the Expert Collection brand. For any pre-submission enquiries, please contact the Commissioning Editor.
From the journal's Aims & Scope
Research area (LetPub): Biochemical Research Methods
Editor-in-chief Christoph BorchersPublisher website
Editorial board by country: 2 in mainland China (about 6%); most named United States 6, United Kingdom 3, Japan 3, Australia 3, Mainland China 2 (31 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Proteomics Techniques and ApplicationsChemistry28.9%
- Mass Spectrometry Techniques and ApplicationsChemistry11.3%
- Metabolomics and Mass Spectrometry StudiesBiochemistry, Genetics and Molecular Biology9.8%
- Advanced Biosensing Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology6.2%
- Monoclonal and Polyclonal Antibodies ResearchMedicine3.7%
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology3.3%
- Bioinformatics and Genomic NetworksBiochemistry, Genetics and Molecular Biology3.2%
- Ubiquitin and proteasome pathwaysBiochemistry, Genetics and Molecular Biology2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemical Research Methods | Zone 3 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemical Research Methods | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemical Research Methods | Zone 3 |
Top journal: noReview journal: yes
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Index Medicus, Biological Abstracts, Biobase, BIOSIS Previews, Index to Scientific Reviews®, Journal Citation Reports/Science Edition
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.93LetPub ·
- Impact factor (publisher) 2025
- 2.9Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.6Publisher website ·
- CiteScore 2026-06
- 4.3LetPub ·
- CiteScore (publisher) 2025
- 4.3Publisher website ·
- SJR 2026-06
- 0.77LetPub ·
- SJR (publisher) 2025
- 0.77Publisher website ·
- SNIP 2026-06
- 0.56LetPub ·
- SNIP (publisher) 2025
- 0.56Publisher website ·
- h-index
- 53LetPub ·
- h-index
- 90OpenAlex ·
- i10-index
- 981OpenAlex ·
- 2-year mean citedness
- 3.62OpenAlex ·
- Self-citation rate
- 3.4%LetPub ·
- Share of gold OA articles
- 11.61%LetPub ·
Volume
- Articles per year
- 41LetPub ·
- Downloads per year (publisher)
- 166,000Publisher website ·
- Downloads per year (publisher) 2025
- 166,000Publisher website ·
Articles by year OpenAlex count · 1,610 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 19 | 6 | 4 |
| 2025 | 47 | 20 | 141 |
| 2024 | 43 | 23 | 250 |
| 2023 | 39 | 13 | 288 |
| 2022 | 25 | 12 | 423 |
| 2021 | 78 | 34 | 1,543 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
82 daysMedian, submission to acceptance · P25–P75 60 days – 115 days
- Acceptance to online
- median 16 days (75 articles)
- Submission to online
- median 109 days
- Sample
- 75 articles with submission and acceptance dates (83 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Acceptance rate (publisher)
- 33%Publisher website ·
- Acceptance rate (publisher) 2025
- 33%Publisher website ·
- Submission to first decision
- 2 daysPublisher website ·
- Submission to first decision 2025
- 2 daysPublisher website ·
- First decision after review
- 33 daysPublisher website ·
- First decision after review 2025
- 33 daysPublisher website ·
- Acceptance to publication
- 14 daysPublisher website ·
- Acceptance to publication 2025
- 14 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Not considered
- case reports; case series
Article types accepted5
- commentaryExpert Review of Proteomics publishes reviews, commentary and original research from the fields of clinical and translational proteomics and related fieldsLength not stated
- editorialEditorial | Published online: 23 Aug 2026Length not stated
- original researchpublishing rigorously peer-reviewed review articles and original research focusing on clinical aspects of proteomicsLength not stated
- reviewReview Article | Published online: 14 Sep 2026Length not stated
- review articlespublishing rigorously peer-reviewed review articles and original research focusing on clinical aspects of proteomicsLength not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Expert Review of Proteomics is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability…
Source ↗Publisher website ·- Peer review
Double-anonymous peer review by independent, expert referees after assessment for suitability by the Editorial Team. Model summary
Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2004
- ISSN
- 1478-9450
- Electronic ISSN
- 1744-8387
- Latest issue on the website
- Volume 23, Issue 7-8 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Expert Review of Proteomics
What CAS zone is Expert Review of Proteomics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Expert Review of Proteomics is in Zone 3 of Biology, and in Zone 3 of the minor category Biochemical Research Methods. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Expert Review of Proteomics?
The latest impact factor listed by LetPub is 2.93; CiteScore 4.3, h-index 90.
How long does peer review take at Expert Review of Proteomics?
Based on the dates recorded on 75 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 82 days (interquartile range 60–115 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”; the journal's website gives an acceptance rate of 33% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Expert Review of Proteomics in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Biology.
Where are the editorial board members of Expert Review of Proteomics based?
Of the 31 board members whose country the journal's board page names, 2 (about 6%) are in mainland China; the countries named most often are United States (6), United Kingdom (3) and Japan (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Expert Review of Proteomics?
According to LetPub and DOAJ records, Expert Review of Proteomics is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Expert Review of Proteomics open access, and what is the APC?
Expert Review of Proteomics is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .